Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00129051 |
Recruitment Status
:
Completed
First Posted
: August 11, 2005
Last Update Posted
: February 9, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Neoplasm Metastasis Carcinoma | Procedure: Tomotherapy | Phase 1 |

Study Type : | Interventional (Clinical Trial) |
Enrollment : | 20 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases |
Study Start Date : | August 2001 |
Study Completion Date : | November 2005 |
- feasibility and tolerance
- efficacy

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Intra-abdominal metastatic cancer
Exclusion Criteria:
- Prior abdominal radiotherapy
- Patient refusal

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00129051
Canada, Alberta | |
Cross Cancer Institute | |
Edmonton, Alberta, Canada, T6G 1Z2 |
Principal Investigator: | Robert Pearcey, MD | AHS Cancer Control Alberta |
ClinicalTrials.gov Identifier: | NCT00129051 History of Changes |
Other Study ID Numbers: |
NA-15-0005 |
First Posted: | August 11, 2005 Key Record Dates |
Last Update Posted: | February 9, 2010 |
Last Verified: | November 2005 |
Keywords provided by AHS Cancer Control Alberta:
tomotherapy metastatic carcinoma |
Additional relevant MeSH terms:
Neoplasm Metastasis Neoplastic Processes Neoplasms Pathologic Processes |